Managing multi-center flow cytometry data for immune monitoring

Cancer Informatics

Volumn 2014, Issue , 2014, Pages 111-122

  White, Scott ^a   Laske, Karoline ^b   Welters, Marij J P ^c   Bidmon, Nicole ^d   van der Burg, Sjoerd H ^c   Britten, Cedrik M ^d   Enzor, Jennifer ^a   Staats, Janet ^a   Weinhold, Kent J ^a   Gouttefangeas, Cécile ^b   Chan, Cliburn ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Automated analysis; Data management; Data provenance; Flow cytometry; Laboratory informatics; Metadata; Reproducible analysis; REST API

Indexed keywords

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ERROR; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFORMATION PROCESSING; INFORMATION SCIENCE; LINGUISTICS; MACHINE LEARNING; MODEL; MONITORING; MULTICENTER STUDY; PIPELINE; PUBLICATION; REPRODUCIBILITY; STATISTICS;

EID: 84981725572     PISSN: None     EISSN: 11769351     Source Type: Journal    
DOI: 10.4137/CIN.S16346     Document Type: Article

References (32)

1. Higano CS, Schellhammer PF, Small EJ, et al. Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer. 2009; 115: 3670-9.
2. Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010; 363: 711-23.
3. Kenter GG, Welters MJ, Valentijn AR, et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N Engl J Med. 2009; 361: 1838-47.
4. Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012; 366: 2443-54.
5. Walter S, Weinschenk T, Stenzl A, et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med. 2012; 18: 1254-61.
6. Fox BA, Schendel DJ, Butterfield LH, et al. Defining the critical hurdles in cancer immunotherapy. J Transl Med. 2011; 9: 214.
7. Herzenberg LA, Tung J, Moore WA, Herzenberg LA, Parks DR. Interpreting flow cytometry data: a guide for the perplexed. Nat Immunol. 2006; 7: 681-5.
8. Chattopadhyay PK, Gaylord B, Palmer A, et al. Brilliant violet fluorophores: a new class of ultrabright fluorescent compounds for immunofluorescence experiments. Cytometry A. 2012; 81: 456-66.
9. Chattopadhyay PK, Roederer M. Cytometry: today’s technology and tomorrow’s horizons. Methods. 2012; 57: 251-8.
10. McNeil LKPL, Britten CM, Jaimes M, et al. A harmonized approach to intracellular cytokine staining gating: results from an international multi-consortia proficiency panel conducted by the cancer immunotherapy consortium (CIC/CRI). Cytometry A. 2013; 83 (8): 728-38.
11. Welters MJ, Gouttefangeas C, Ramwadhdoebe TH, et al. Harmonization of the intracellular cytokine staining assay. Cancer Immunol Immunother. 2012; 61: 967-78.
12. Britten CM, Janetzki S, Butterfield LH, et al. T cell assays and MIATA: the essential minimum for maximum impact. Immunity. 2012; 37: 1-2.
13. Janetzki S, Britten CM, Kalos M, et al. “MIATA”-minimal information about T cell assays. Immunity. 2009; 31: 527-8.
14. Lee JA, Spidlen J, Boyce K, et al; International Society for Advancement of Cytometry Data Standards Task Force. MIFlowCyt: the minimum information about a flow cytometry experiment. Cytometry A. 2008; 73: 926-30.
15. Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat Rev Immunol. 2012; 12: 191-200.
16. Mahnke Y, Chattopadhyay P, Roederer M. Publication of optimized multicolor immunofluorescence panels. Cytometry A. 2010; 77: 814-8.
17. van der Burg SH, Kalos M, Gouttefangeas C, et al. Harmonization of immune biomarker assays for clinical studies. Sci Transl Med. 2011; 3: 108s44.
18. Britten CM, Gouttefangeas C, Welters MJ, et al. The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol Immunother. 2008; 57: 289-302.
19. Staats JS, Enzor JH, Sanchez AM, et al. Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays. J Immunol Methods. 2014; 409C: 44-53.
20. Attig S, Price L, Janetzki S, et al; CRI-CIC Assay Working Group. A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols. J Transl Med. 2011; 9: 108.
21. Frelinger J, Ottinger J, Gouttefangeas C, Chan C. Modeling flow cytometry data for cancer vaccine immune monitoring. Cancer Immunol Immunother. 2010; 59: 1435-41.
22. Aghaeepour N, Finak G, Hoos H, et al; FlowCAP Consortium; DREAM Consortium. Critical assessment of automated flow cytometry data analysis techniques. Nat Methods. 2013; 10: 228-38.
23. O’Neill K, Aghaeepour N, Spidlen J, Brinkman R. Flow cytometry bioinformatics. PLoS Comput Biol. 2013; 9: e1003365.
24. Spidlen J, Shooshtari P, Kollmann TR, Brinkman RR. Flow cytometry data standards. BMC Res Notes. 2011; 4: 50.
25. Britten CM, Janetzki S, van der Burg SH, Gouttefangeas C, Hoos A. Toward the harmonization of immune monitoring in clinical trials: quo vadis? Cancer Immunol Immunother. 2008; 57: 285-8.
26. Lewis SM. Standardization and harmonization of the blood count: the role of international committee for standardization in haematology (ICSH). Eur J Haematol Suppl. 1990; 53: 9-13.
27. Richards AJ, Staats J, Enzor J, et al. Setting objective thresholds for rare event detection in flow cytometry. J Immunol Methods. 2014; 409: 54-61.
28. Cron A, Gouttefangeas C, Frelinger J, et al. Hierarchical modeling for rare event detection and cell subset alignment across flow cytometry samples. PLoS Comput Biol. 2013; 9: e1003130.
29. Lin L, Chan C, Hadrup SR, Froesig TM, Wang Q, West M. Hierarchical bayesian mixture modelling for antigen-specific T-cell subtyping in combinatorially encoded flow cytometry studies. Stat Appl Genet Mol Biol. 2013; 12 (3): 309-31.
30. Chan C, Lin L, Frelinger J, et al. Optimization of a highly standardized carboxyfluorescein succinimidyl ester flow cytometry panel and gating strategy design using discriminative information measure evaluation. Cytometry A. 2010; 77: 1126-36.
31. Suchard MA, Wang Q, Chan C, Frelinger J, Cron A, West M. Understanding GPU programming for statistical computation: studies in massively parallel massive mixtures. J Comput Graph Stat. 2010; 19: 419-38.
32. Roederer M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry. 2001; 45: 194-205.